The Asia-Pacific (APAC) infusion pumps market is projected to grow from USD 3.7 billion in 2022 to USD 5.7 billion by 2027, at a CAGR of 9.1%, according to MarketsandMarkets. This robust growth is fueled by the rising demand for ambulatory infusion pumps in home care, the growing prevalence of chronic diseases, a rapidly aging population, the increase in surgical procedures, and the expansion of ICU capacity—particularly in countries with high COVID-19 incidence.
However, challenges such as product recalls, stringent regulatory approvals, increasing adoption of refurbished pumps, medication errors, and limited wireless connectivity in hospitals continue to restrain market growth. On the upside, emerging markets and specialty infusion systems present strong opportunities for expansion.
Market Segmentation Insights
- By Product:
- Accessories & Consumables are expected to record the highest CAGR due to their recurrent use and rising adoption of infusion pumps for controlled drug delivery.
- Within this segment, dedicated accessories & consumables hold the largest market share, as manufacturers increasingly require pump-specific administration sets to ensure optimal performance.
- By Device Type:
- Portable infusion pumps are anticipated to see the fastest growth, driven by technological advancements and growing adoption in home care, especially for insulin delivery and ambulatory chemotherapy.
- By Application:
- Chemotherapy/Oncology dominates the market, supported by the rising cancer incidence, increased availability of ambulatory pumps for chemotherapy, and advanced product innovations.
- By End User:
- Hospitals remain the largest revenue contributor, backed by their strong purchasing power, large patient volumes, and availability of trained staff to operate infusion devices.
Regional Highlights
China is expected to register the highest CAGR in the APAC infusion pumps market during the forecast period. This growth is driven by:
- An expanding geriatric population
- Higher chronic disease prevalence
- Increasing hospital infrastructure
- Improved healthcare access and insurance coverage
- Strong demand for advanced infusion technologies, especially during the COVID-19 pandemic
Key Market Players
The APAC infusion pumps market is dominated by global and regional leaders, including:
Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), Baxter International (US), Medtronic PLC (Ireland), ICU Medical (US), Terumo Corporation (Japan), Nipro Corporation (Japan), Abbott Laboratories (US), Mindray Medical (China), and others.